Impaired sphingomyelinase activity and epidermal differentiation in atopic dermatitis

Journal of Investigative Dermatology

Volumn 122, Issue 6, 2004, Pages 1423-1431

  Jensen, Jens Michael ^a   Fölster Holst, Regina ^a   Baranowsky, Anke ^a   Schunck, Michael ^a   Winoto Morbach, Supandi ^a   Neumann, Claudia ^a   Schütze, Stefan ^a   Proksch, Ehrhardt ^a,b  

^a UNIVERSITY OF KIEL   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

Atopic dermatitis; Filaggrin; Involucrin; Keratin; Loricrin; Sphingomyelinase

Indexed keywords

CERAMIDE; ENVELOPE PROTEIN; FILAGGRIN; INVOLUCRIN; KERATIN; LORICRIN; SPHINGOMYELIN PHOSPHODIESTERASE;

ARTICLE; ATOPIC DERMATITIS; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SYNTHESIS; ENZYME ACTIVITY; EPIDERMIS; HUMAN; HUMAN TISSUE; PERMEABILITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; SKIN DEFECT; STRATUM CORNEUM;

EID: 2942620512     PISSN: 0022202X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0022-202X.2004.22621.x     Document Type: Article

References (79)

1. Al-Jaberi H, Marks R: Studies of the clinically uninvolved skin in patients with dermatitis. Br J Dermatol 111:437-443, 1984
2. Altemus M, Rao B, Dhabhar FS, Ding W, Granstein RD: Stress-induced changes in skin barrier function in healthy women. J Invest Dermatol 117:309-317, 2001
3. Barth J, Gatti S, Jatzke M: Skin surface lipids in atopic eczema and ichthyosis. Chron Derm 10:609-612, 1989
4. Bos JD, Kapsenberg ML, Smitt JH: Pathogenesis of atopic eczema. Lancet 343:1338-1341, 1994
5. Bowser PA, Gray PM: Sphingomyelinase in pig and human epidermis. J Invest Dermatol 70:331-335, 1978
6. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72:248-254, 1976
7. Buisson-Legendre N, Bernard P, Bobichon H, et al: Involvement of the 92-kDa gelatinase (matrix metalloproteinase-9) in the ceramide-mediated inhibition of human keratinocyte growth. Biochem Biophys Res Commun 260:634-640, 1999
8. Cline PR, Rice RH: Modulation of involucrin and envelope competence in human keratinocytes by hydrocortisone, retinyl acetate, and growth arrest. Cancer Res 43:3203-3207, 1983
9. Cookson WO, Ubhi B, Lawrence R, et al: Genetic linkage of childhood atopic dermatitis to psoriasis susceptibility loci. Nat Genet 27:372-373, 2001
10. Di Nardo A, Wertz P, Giannetti A, Seidenari S: Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 78:27-30, 1998
11. Ekanayake-Mudiyanselage S, Aschauer H, Schmook FP, Jensen JM, Meingassner JG, Proksch E: Expression of epidermal keratins and the cornified envelope protein involucrin is influenced by permeability barrier disruption. J Invest Dermatol 111:517-523, 1998
12. Elias PM, Menon GK: Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 24:1-26, 1991
13. Elias PM, Wood LC, Feingold KR: Relationship of the epidermal permeability barrier to irritant contact dermatitis. In: Beltrani V (ed). Immunology and Allergy Clinics of North America. Vol. 17: Contact Dermatitis: Irritant and Allergic. Philadelphia: Saunders, 1997; p 417-430
14. Elias PM, Wood LC, Feingold KR: Epidermal pathogenesis of inflammatory dermatoses. Am J Contact Derm 10:119-126, 1999
15. Engelke M, Jensen JM, Ekanayake-Mudiyanselage S, Proksch E: Effects of xerosis and ageing on epidermal proliferation and differentiation. Br J Dermatol 137:219-225, 1997
16. Freinkel RK, Traczyk TN: Acid hydrolases of the epidermis: Subcellular localization and relationship to cornification. J Invest Dermatol 80:441-446, 1983
17. Fuchs E, Green H: Changes in keratin gene expression during terminal differentiation of the keratinocyte. Cell 19:1033-1042, 1980
18. Garg A, Chren MM, Sands LP, Matsui MS, Marenus KD, Feingold KR, Elias PM: Psychological stress perturbs epidermal permeability barrier homeostasis: Implications for the pathogenesis and treatment of stress-associated skin disorders. Arch Dermatol 137:53-59, 2001
19. Gfesser M, Rakoski J, Ring J: The disturbance of epidermal barrier function in atopy patch test reactions in atopic eczema. Br J Dermatol 135:560-565, 1996
20. Ghadially R, Halkier-Sorensen L, Elias PM: Effects of petrolatum on stratum corneum structure and function. J Am Acad Dermatol 26:387-396, 1992
21. Hanifin JM, Rajka G: Diagnostic features of atopic dermatitis. Acta Derm Venerol Suppl 92:44-47, 1980
22. Hara J, Higuchi K, Okamoto R, Kawashima M, Imokawa G: High-expression of sphingomyelin deacylase is an important determinant of ceramide deficiency leading to barrier disruption in atopic dermatitis. J Invest Dermatol 115:406-413, 2000
23. Hashimoto-Kumasaka K, Takahashi K, Tagami H: Electrical measurement of the water content of the stratum corneum in vivo and in vitro under various conditions: Comparison between skin surface hygrometer and corneometer in evaluation of the skin surface hydration state. Acta Derm Venereol 73:335-339, 1993
24. Hazelbag HM, van den Broek LJ, van Dorst EB, Offerhaus GJ, Fleuren GJ, Hogendoorn PC: Immunostaining of chain-specific keratins on formalin-fixed, paraffin-embedded tissues: A comparison of various antigen retrieval systems using microwave heating and proteolytic pre-treatments. J Histochem Cytochem 43:429-437, 1995
25. Higuchi K, Hara J, Okamoto R, Kawashima M, Imokawa G: The skin of atopic dermatitis patients contains a novel enzyme, glucosylceramide sphingomyelin deacylase, which cleaves the N-acyl linkage of sphingomyelin and glucosylceramide. Biochem J 350:747-756, 2000
26. Hohl D: Expression patterns of loricrin in dermatological disorders. Am J Dermatopathol 15:20-27, 1993
27. Holleran WM, Feingold KR, Man MQ, Gao WN, Lee JM, Elias PM: Regulation of epidermal sphingolipid synthesis by permeability barrier function. J Lipid Res 32:1151-1158, 1991
28. Holleran WM, Man MQ, Gao WN, Menon GK, Elias PM, Feingold KR: Sphingolipids are required for mammalian epidermal barrier function: Inhibition of sphingolipid synthesis delays barrier recovery after acute perturbation. J Clin Invest 88:1338-1345, 1991
29. Holleran WM, Takagi Y, Menon GK, Jackson SM, Lee JM, Feingold KR, Elias PM: Permeability barrier requirements regulate epidermal beta- glucocerebrosidase. J Lipid Res 35:905-912, 1994
30. Holleran WM, Takagi Y, Menon GK, Legier G, Feingold KR, Elias PM: Processing of epidermal glucosylceramides is required for optimal mammalian cutaneous permeability barrier function. J Clin Invest 91:1656-1664, 1993
31. Imokawa G, Abe A, Jin Y, Higaki Y, Kawashima M, Hidano A: Decreased level of ceramides in stratum corneum of atopic dermatiti: An etiologic factor in atopic dry skin? J Invest Dermatol 96:523-526, 1991
32. Imokawa G: Lipid abnormalities in atopic dermatitis. J Am Acad Dermatol 45:S29-S32, 2001
33. Jakobza D, Reichmann G, Langnick W, Langnick A, Schulze P: Surface skin lipids in atopic dermatitis. Dermatol Monatsschr 167:26-29, 1981
34. Jensen JM, Schütze S, Förl M, Krönke M, Proksch E: Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier. J Clin Invest 104:1761-1770, 1999
35. Jensen JM, Schutze S, Neumann C, Proksch E: Impaired cutaneous permeability barrier function, skin hydration, and sphingomyelinase activity in keratin 10 deficient mice. J Invest Dermatol 115:708-713, 2000
36. Jin K, Higaki Y, Takagi Y, Higuchi K, Yada Y, Kawashima M, Imokawa G: Analysis of beta-glucocerebrosidase and ceramidase activities in atopic and aged dry skin. Acta Derm Venereol 74:337-340, 1994
37. Korneva EA, Shanin SN, Rybakina EG: The role of interleukin-1 in stress-induced changes in immune system function. Neurosci Behav Physiol 31:431-437, 2001
38. Kusuda S, Cui CY, Takahashi M, Tezuka T: Localization of sphingomyelinase in lesional skin of atopic dermatitis patients. J Invest Dermatol 111:733-738, 1998
39. Lee SH, Elias PM, Proksch E, Menon GK, Mao-Qiang M, Feingold KR: Calcium and potassium are important regulators of barrier homeostasis in murine epidermis. J Clin Invest 89:530-538, 1992
40. Macheleidt O, Kaiser HW, Sandhoff K: Deficiency of epidermal protein-bound ω-hydroxyceramides in atopic dermatitis. J Invest Dermatol 119:166-173, 2002
41. Marekov LN, Steinert PM: Ceramides are bound to structural proteins of the human foreskin epidermal cornified cell envelope. J Biol Chem 273:17763-17770, 1998
42. Matsumoto M, Sugiura H, Uehara M: Skin barrier function in patients with completely healed atopic dermatitis. J Dermatol Sci 23:178-182, 2000
43. + gradients in murine epidermis: Quantitative measurement using PIXE. J Invest Dermatol 111:1198-1201, 1998
44. Mauro T, Holleran WM, Grayson S, et al: Barrier recovery is impeded at neutral pH, independent of ionic effects: Implications for extracellular lipid processing. Arch Dermatol Res 290:215-222, 1998
45. McNally NJ, Williams HC, Phillips DR, Smallman-Rayanor M, Lems S, Venn A, Britton J: Atopic eczema and domestic water hardness. Lancet 352:527-531, 1998
46. Meguro S, Arai Y, Masukawa Y, Uie K, Tokimitsu I: Relationship between covalently bound ceramides and transepidermal water loss (TEWL). Arch Dermatol Res 292:463-468, 2000
47. Mehrel T, Hohl D, Rothnagel JA, et al: Identification of a major keratinocyte cell envelope protein, loricrin. Cell 61:1103-1112, 1990
48. Melnik B, Hollmann J, Plewig G: Decreased stratum corneum ceramides in atopic individuals - a pathobiochemical factor in xerosis? Br J Dermatol 119:547-549, 1988
49. Melnik BC, Hollmann J, Erler E, Verhoeven B, Plewig G: Microanalytical screening of all major stratum corneum lipids by sequential high-performance thin-layer chromatography. J Invest Dermatol 92:231-234, 1989
50. Melnik BC, Plewig G: Is the origin of atopy linked to deficient conversion of omega-6-fatty acids to prostaglandin E1? J Am Acad Dermatol 21:557-563, 1989
51. Moll R, Moll I, Franke WW: Differences of expression of cytokeratin polypeptides in various epithelial skin tumors. Arch Dermatol Res 276:349-363, 1984
52. Murata Y, Ogata J, Higaki Y, et al: Abnormal expression of sphingomyelin acylase in atopic dermatiti: An etiologic factor for ceramide deficiency? J Invest Dermatol 106:1242-1249, 1996
53. Mustakallio KK, Kiistala U, Piha HJ, Nieminen E: Epidermal lipids in Besnier's prurigo (atopic eczema). Ann Med Exp Biol Fenn 45:323-325, 1967
54. Nassif A, Chan SC, Storrs FJ, Hanifin JM: Abnormal skin irritancy in atopic dermatitis and in atopy without dermatitis. Arch Dermatol 130:1402-1407, 1994
55. Ogawa H, Yoshiike TJ: A speculative view of atopic dermatitis: Barrier dysfunction in pathogenesis. Dermatol Sci 5:197-204, 1993
56. Pinnagoda J, Tupker RA, Agner T, Serup J: Guidelines for transepidermal water loss (TEWL) measurement. A report from the Standardization Group of the European Society of Contact Dermatitis. Contact Dermatitis 22:164-181, 1990
57. Proksch E, Feingold KR, Mao-Quiang M, Elias PM: Barrier function regulates epidermal DNA-synthesis. J Clin Invest 87:1668-1673, 1991
58. Proksch E, Jensen J, Elias PM: Skin lipids and epidermal differentiation in atopic dermatitis. Clin Dermatol 21:134-144, 2003
59. Redoutes D, Tarroux R, Assalit MF, Peri JJ: Characterisation and assay of five enzymatic activities in the stratum corneum using tape-strippings. Skin Pharmacol Appl Skin Physiol 12:182-192, 1999
60. Robson KJ, Stewart ME, Michelsen S, Lazo ND, Downing DT: 6-Hydroxy-4-sphingenine in human epidermal ceramides. J Lipid Res 35:2060-2068, 1994
61. Rosenthal DS, Griffiths CE, Yuspa SH, Roop DR, Voorhees JJ: Acute or chronic topical retinoic acid treatment of human skin in vivo alters the expression of epidermal transglutaminase, loricrin, involucrin, filaggrin, and keratins 6 and 13 but not keratins 1, 10, and 14. J Invest Dermatol 98:343-350, 1992
62. Schäfer L, Kragballe K: Abnormalities in epidermal lipid metabolism in 11 patients with atopic dermatitis. J Invest Dermatol 96:10-15, 1991
63. Schmuth M, Man MQ, Weber F, et al: Permeability barrier disorder in Niemann-Pick disease: Sphingomyelin-ceramide processing required for normal barrier homeostasis. J Invest Dermatol 115:459-466, 2000
64. Schürer NY, Elias PM: The biochemistry and function of stratum corneum lipids. Adv Lipid Res 24:27-56, 1991
65. Scott IR, Harding CR: Filaggrin breakdown to water binding compounds during development of the rat stratum corneum is controlled by the water activity of the environment. Dev Biol 115:84-92, 1986
66. Seguchi T, Cui CY, Kusuda S, Takahashi M, Aisu K, Tezuka T: Decreased expression of filaggrin in atopic skin. Arch Dermatol Res 238:442-446, 1996
67. Uchida Y, Hara M, Nishio H, et al: Epidermal sphingomyelins are precursors for selected stratum corneum ceramides. J Lipid Res 41:2071-2082, 2000
68. Van Neste D, Lachapelle JM, Desmons F: Atopic dermatitis: A Histologic and Radioautographic Study (after 3H-Thymidine Labelling) of Epidermal and Dermal Lesions. Ann Dermatol Venereol 106:327-335, 1979
69. Vicanova J, Boyoe ST, Harriger MD, Weerheim AM, Bouwstra JA, Ponec M: Stratum corneum lipid composition and structure in cultured skin substitutes is restored to normal after grafting onto athymic mice. J Invest Dermatol Symp Proc 3:114-120, 1998
70. Watanabe M, Tagami H, Horii I, Takahashi M, Kligman AM: Functional analyses of the superficial stratum corneum in atopic xerosis. Arch Dermatol 127:1689-1692, 1991
71. Watt FM: Involucrin and other markers of keratinocyte terminal differentiation. J Invest Dermatol 81 (1 Suppl.):100s-103s, 1983
72. Wertz PW, Downing DT: Covalent attachment of omega-hydroxyacid derivatives to epidermal macromolecules: A preliminary characterization. Biochem Biophys Res Commun 137:992-997, 1986
73. Wertz PW, Swartzendruber DC, Kitko DJ, Madison KC, Downing DT: The role of the corneocyte lipid envelopes in cohesion of the stratum corneum. J Invest Dermatol 93:169-172, 1989
74. Wiegmann K, Schütze S, Machleidt T, Witte D, Krönke M: Functional dichotomy of neutral and acid sphingomyelinase in tumor necrosis factor signaling. Cell 78:1005-1015, 1994
75. Wood LC, Jackson SM, Elias PM, Grunfeld C, Feingold KR: Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest 90:482-487, 1992
76. Wood LC, Elias PM, Calhoun C, Tsai JC, Grunfeld C, Feingold KR: Barrier disruption stimulates interleukin-1 alpha expression and release from a preformed pool in murine epidermis. J Invest Dermatol 106:397-403, 1996
77. Yamamoto A, Serizawa S, Ito M, Sato Y: Stratum corneum lipid abnormalities in atopic dermatitis. Arch Dermatol Res 283:219-223, 1991
78. Yoneda K, Hohl D, McBride OW, Wang M, Cehrs KU, Idler WW, Steinert PM: The human loricrin gene. J Biol Chem 267:18060-18066, 1992
79. Yoshiike T, Aikawa Y, Sindhvananda J, Suto H, Nishimura K, Kawamoto T, Ogawa H: Skin barrier defect in atopic dermatitis: Increased permeability of the stratum corneum using dimethyl sulfoxide and theophylline. J Dermatol Sci 5:92-96, 1993